Orchid Island: The Convexity Shock Was the Quarter; the Hedge Book Was the Fix

Orchid Island: The Convexity Shock Was the Quarter; the Hedge Book Was the Fix

For a leveraged agency mortgage REIT, a quarter like Orchid Island's third quarter is a test of whether the balance sheet forces your hand. It didn't—but the damage was real. The company reported a net loss of $0.90 per share, book value fell to $6.02 from $7.22, and total return including dividends was negative 12.5%. The stock has already voted: down 23.6% over 90 days and 27.8% from its July 16 peak of $6.99, against a full-history drawdown of 93.2% from 2014. That is the backdrop for a report that is less about a new strategy than about how management defended an old one.

The quarter was a convexity event, not a credit event

Bob Cauley did not bury the lede: “the big story in Q3 was this material sell-off in the rates market that occurred right at the end of the quarter” — Robert Cauley, Chief Executive Officer · 2026-10-23. The 10-year broke out of its range, climbed into the 4.70s and approached 5%, and the mortgage universe repriced violently. This was a convexity-related sell-off: as rates rose, mortgage durations extended, levered investors hedged or deleveraged, and the CMO floater market that had been absorbing specified-pool supply slowed sharply. Hunter Haas described the sequence plainly—specified pools had held in until rates moved higher and CMO floater demand faded, then higher pay-up pools, especially low-loan-balance and New York collateral, saw pay-ups fall versus TBA.

The operating numbers show the stress. Average portfolio size slipped to $11.1 billion from $11.4 billion, 3-month CPR fell to 8.4% from 10.9%, leverage jumped to 8.6x from 7.3x, and liquidity dropped to 44% from 54%. On the last filed balance sheet, liabilities were already 89% of assets, with stockholders' equity of $1.44 billion. The Q3 hit came after that snapshot; the point is that Orchid entered the sell-off with a thin equity cushion and a large repo book.

What changed: the hedge book, not the asset book

The most important decision was not to sell the portfolio. Instead, Orchid adjusted the liability side. Hedge coverage went from 91% to 99%, and the mix shifted toward futures: “we wanted to do our hedging in the futures market more so than swaps just because swap spreads have widened so much” — Robert Cauley, Chief Executive Officer · 2026-10-23. The company replaced $1.6 billion of short-dated swaps with equivalent DV01 in 10-year Treasury futures, added short positions in 7-year, 10-year and 30-year futures, and unwound a 3-month into 5-year payer swaption near max value for roughly a 200% return on premium. It also sold low pay-up 30-year 5s against a TBA short to bolster cash and bring leverage down.

This matters because it directly addresses a vulnerability management had flagged three months earlier. On the July call, Cauley said: “Our hedge coverage is at a very high percent. ... about 91%. ... there would be some leakage into our funding cost.” — Robert E. Cauley, CEO · 2026-07-24 Raising coverage to 99% and shifting to an alternative hedge mix is a concrete fix to that leakage—one that preserves the asset base and its prospective returns rather than crystallizing losses. It is also why the October rebound matters: Haas said book value rose about 4.5% month-to-date through October 22, and leverage was back to 8.12x.

The tone changed, but only weeks ago

Three months ago the message was darker. Cauley warned: “I do not see any end in sight of the war. In fact, I suspect that it is probably gonna get worse.” — Robert E. Cauley, CEO · 2026-07-24 He also said the market was “in the midst of a move to a higher level of rates. And cheapening of mortgages.” — Robert E. Cauley, CEO · 2026-07-24 The current call says the opposite has happened: rates stabilized after the quarter, the oil/rates correlation broke, and Treasuries regained safe-haven status. That is a real change in market behavior, but it is only a few weeks old, and Cauley was careful to say the rally 'petered out today' and that he does not know what happens next. So this is a stabilization call, not an all-clear.

The discount is the strategy—and the constraint

For shareholders, the most important capital-allocation fact is that Orchid's stock is trading at a deep discount to book. Management said the shares were more than 20% below estimated current book value as of October 22. Cauley was blunt:

The big takeaway though is with the stock trading where it is, it's really an albatross around our neck. ... We're not willing to sell shares at anywhere close to this level of a discount.

That flips the usual mortgage REIT playbook. Peers trading at premiums can issue accretively and buy assets; Orchid cannot. Instead it repurchased 6.62 million shares since the end of Q2 and about 1.7 million in Q4, and it will weigh further buybacks against adding mortgage assets. The dividend was left at $0.30; management says taxable income is in line and it is comfortable with the pay rate, with portfolio returns in the high teens at current leverage. The high mortgage rate environment helps carry by keeping prepayments low, but it also keeps housing affordability poor and origination volumes weak. A rates rally would help book value but compress reinvestment yields; a renewed sell-off would do the opposite. That is the narrow path Orchid is managing.

Bottom line: Q3 was a stress test, not a thesis break. Orchid took a 17% book-value hit, raised hedge coverage, shifted the hedge mix to futures, avoided forced asset sales, and is now using a deep share discount as a capital-return tool. The risk is that the October recovery is another brief episode in a market that has produced several. The reward is that if rates stay stable, book value recovers and high-teens ROE becomes visible again—provided the stock's discount eventually closes enough to make the equity currency useful.